Prognostic impact of late gadolinium enhancement at the right ventricular insertion points in non-ischaemic dilated cardiomyopathy. (14th June 2022)

• Record Type: Journal Article
• Authors: Claver, Eduard; Di Marco, Andrea; Brown, Pamela Frances; Bradley, Joshua; Nucifora, Gaetano; Ruiz-Majoral, Alejandro; Dallaglio, Paolo Domenico; Rodriguez, Marcos; Comin-Colet, Josep; Anguera, Ignasi; Miller, Christopher A; Schmitt, Matthias
• Is Part Of: European heart journal. Volume 24:Number 3(2023)
• Page Start: 346
• Page End: 353
• Publication Date: 2022-06-14
• Subjects: cardiac magnetic resonance -- non-ischaemic dilated cardiomyopathy -- ventricular arrhythmias -- sudden death -- late gadolinium enhancement; Cardiovascular system -- Imaging -- Periodicals; Heart -- Imaging -- Periodicals; 616.10754
• DOI: 10.1093/ehjci/jeac109
• Languages: English
• ISSNs: 2047-2404

Abstract

Abstract: Aims: To evaluate the baseline characteristics and the prognostic implications associated with late gadolinium enhancement limited to the right ventricular insertion points (IP-LGE) or present at both the right ventricular insertion points and the left ventricle (IP&LV-LGE) in non-ischaemic dilated cardiomyopathy (DCM). Methods and results: This is a retrospective observational multicentre cohort study including 1165 consecutive patients with DCM evaluated by cardiac magnetic resonance. The primary endpoint included appropriate defibrillator therapies, sustained ventricular tachycardia, resuscitated cardiac arrest, or sudden death. The secondary outcome encompassed heart failure hospitalizations, heart transplant, left ventricular assist device implantation, and end-stage heart failure death. IP-LGE was found in 72 patients (6%), who had clinical characteristics closer to LGE− than to LGE+ patients. During follow-up (median 36 months), none of the IP-LGE patients experienced the primary endpoint. The cumulative incidence of the primary endpoint was similar between IP-LGE and LGE− patients ( P = 1), while IP-LGE had significantly lower cumulative incidence when compared with LGE+ patients ( P < 0.001). When compared with IP-LGE patients, the cumulative incidence of the secondary endpoint was similar in LGE− cases ( P = 0.86) but tended to be higher in LGE+ patients ( P = 0.06). Both clinical characteristics and outcomes were similar between IP&LV-LGE patients and the rest of LGE+ cases. Conclusions: In a large cohort of DCM patients, IP-LGE was associated with similar outcome when compared with LGE− patients and with significant lower risk of ventricular arrhythmias and sudden death when compared with LGE+ cases. Patients with IP&LV-LGE had clinical characteristics and outcomes similar to the rest of LGE+ cases.